Rest of world — Long-Lived Assets

Geographic · Long-Lived Assets

Eli Lilly Rest of world — Long-Lived Assets increased by 62.9% to $3.52B in Q4 2025 compared to the prior quarter.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025

How to read this metric

An increase suggests significant capital investment in international infrastructure to support future growth, whereas a decrease may indicate asset divestiture or a shift in the company's global operational strategy.

Detailed definition

This metric measures the book value of non-current, tangible, and intangible assets located in international geographic...

Peer comparison

Similar to 'Property, Plant, and Equipment' or 'Long-Lived Assets by Geography' reported by other multinational pharmaceutical companies.

Metric ID: lly_segment_rest_of_world_long_lived_assets

Historical Data

3 periods
 Q4 '23Q4 '24Q4 '25
Value$1.78B$2.16B$3.52B
QoQ Change+21.0%+62.9%
YoY Change+21.0%+62.9%
Range$1.78B$3.52B
Avg YoY Growth+41.9%
Median YoY Growth+41.9%
Current Streak2+ quarters growth

Frequently Asked Questions

What is Eli Lilly's rest of world — long-lived assets?
Eli Lilly (LLY) reported rest of world — long-lived assets of $3.52B in Q4 2025.
What does rest of world — long-lived assets mean?
The total value of the company's long-term physical and intangible assets located outside of its home country.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.